• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer

Drug Delivery Business

  • Clinical Trials
  • Research & Development
  • Drug-Device Combinations
  • FDA
  • Pharmaceuticals
  • Policy

UCB’s Cimzia AutoClicks pen hits the U.K. market

October 25, 2016 By Sarah Faulkner

UCB's Cimzia AutoClicks pen hits the U.K. marketUCB (EBR:UCB) said today that its Cimzia AutoClicks pre-filled pen is available in the U.K., after the European Medicines Agency’s Committee for Medicinal Products for Human Use recommended the device for all approved indications, including rheumatoid arthritis and axial spondyloarthritis.

The Belgian company partnered with OXO to develop the pen, based on technology licensed from Bespak. The AutoClicks device is button-free with a wide, non-slip grip to help patients that experience pain when trying to grip an object. The pen clicks when the injection has started and when it has finished to ensure the patient receives a full dose of certolizumab pegol.

“I see many patients whose joints have been destroyed by this painful disease so having a new choice is welcomed,” Dr. Ravik Mascarenhas, a rheumatologist at the Royal Devon & Exeter Foundation Trust, said in prepared remarks. “Like most of us they also tend to find it a challenge self-injecting because of a needle – with this new pre-filled pen the patient doesn’t even see the needle which may take some of the nerves and fear away.”

“It is difficult for people who do not suffer from this disease to understand just how challenging doing the ordinary things in daily life can be, more so for those with painful and swollen joints,” added National Rheumatoid Arthritis Society CEO Ailsa Bosworth. “Trying to grip an everyday object such as a kitchen gadget can cause immense pain. So we welcome any innovation that can help make the lives of RA patients more comfortable while they manage their condition.”

The monthly cost to the U.K.’s National Health Service for treating a patient using the AutoClicks pen is about $867 (£715) for 2 treatment doses of 200mg, according to UCB.

Filed Under: Auto-injectors, Featured, Orthopedics, Pharmaceuticals Tagged With: UCB

IN CASE YOU MISSED IT

  • Senseonics stock is up as it sticks by revenue guidance
  • MedAlliance wins second FDA IDE nod for drug-coated balloon
  • Wells Fargo downgrades Tandem amid rise of automated insulin delivery competition
  • FDA approves first targeted infusion therapy for HER2-low breast cancer
  • Abbott, WeightWatchers partner on diabetes care

Primary Sidebar

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Need Drug Delivery Business News in a minute? We Deliver!
Drug Delivery Enewsletters get you caught up on all the mission critical news you need in med tech. Sign up today.

Signup for the newsletter

Footer

Drug Delivery Business News Logo

MassDevice Medical NETWORK

MassDevice
DeviceTalks
Medical Tubing & Extrusion
Medical Design & Outsourcing
MedTech100 Index
Drug Discovery & Development
Pharmaceutical Processing World
Medical Design Sourcing
R&D World

DRUG DELIVERY BUSINESS NEWS

Subscribe to Drug Delivery’s E-Newsletter
Advertise with us
About
Contact us
Privacy
Listen to our Weekly Podcasts
Add us on FacebookFollow us on TwitterConnect with us on LinkedIn

Copyright © 2022 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Advertise | Privacy Policy | RSS